Trials / Unknown
UnknownNCT00418197
Total Facet Arthroplasty System®(TFAS®) Clinical Trial
A Prospective and Randomized Controlled Trial to Evaluate the Safety and Effectiveness of Total Facet Arthroplasty in the Treatment of Degenerative Spinal Stenosis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 450 (estimated)
- Sponsor
- Archus Orthopedics, Inc. · Industry
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The Archus Total Facet Arthroplasty System® (TFAS®) is a non-fusion spinal implant indicated for treatment of patients with moderate to severe spinal stenosis. TFAS® replaces the diseased facets following surgical removal. TFAS® offers the surgeon new options for treating spinal stenosis patients, enabling a more comprehensive decompression via complete removal of the facets. TFAS® also offers an alternative to rigid spinal fusion fixation enabling intervertebral motion. The clinical trial is intended to demonstrate restoration of stability and sagittal balance to the spine. TFAS® also eliminates the need for painful bone graft harvest from the patient's hip which may be required with fusion procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Total Facet Arthroplasty System® (TFAS®) |
Timeline
- Start date
- 2005-08-01
- First posted
- 2007-01-04
- Last updated
- 2009-02-05
Source: ClinicalTrials.gov record NCT00418197. Inclusion in this directory is not an endorsement.